Cellular Oncology

Article	Citations
Retraction Note: Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications	148
Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b+CD64+ patients with acute myeloid leukemia	76
Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test	60
Methionine-producing tumor micro(be) environment fuels growth of solid tumors	56
The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacy	42
O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency	41
Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor	41
Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis	39
Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach	36
Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer	34
Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells	30
Single-cell RNA transcriptomic analyses of tumor microenvironment of ovarian metastasis in gastric cancer	30
Chordoma cells possess bone-dissolving activity at the bone invasion front	28
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion	28
Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer	27
A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms	27
Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model	27
LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation	26
Marine derived macrolide bryostatin 4 inhibits the TGF-β signaling pathway against acute erythroleukemia	23
COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling	23
Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma	23
Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer	22
Characterization and proteomic analysis of plasma-derived small extracellular vesicles in locally advanced rectal cancer patients	22
Mapping the immune terrain in lung adenocarcinoma progression: Tfh-like cells in tertiary lymphoid structures	22
Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy	21

YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models	21
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy	20
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells	20
CDK7 blockade suppresses super‐enhancer‐associated oncogenes in bladder cancer	20
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer	20
STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma	19
Multi-dimensional characterization of apoptosis in the tumor microenvironment and therapeutic relevance in melanoma	19
Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis	18
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression	18
DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma	18
MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer	17
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer	17
Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway	17
Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer	17
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma	17
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition	17
LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing	16
Application of circulating tumour cells to predict response to treatment in head and neck cancer	16
The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma	16
Cell death in glioblastoma and the central nervous system	15
The therapeutic potential of exosomes in lung cancer	15
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma	14
Unveiling therapeutic avenues targeting xCT in head and neck cancer	14
The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axis	14
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities	14
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin	14
Correction to: Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study	13
Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production	13
Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin	13
HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma	13
FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling	12
Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma	12
ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer	12
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression	12
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer	12
Correction to: Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling	11
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway	11
Correction to: Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis	11
Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer	11
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression	11
Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissue	10
In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)	10
Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling	10
RETRACTED ARTICLE: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling	10
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis	10
CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation	10
Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis	10
Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming	10
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer	10
Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution	10

Correction to: H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis	10
Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma	9
SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma	9
IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells	9
Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors	9
ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways	9
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex	9
Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma	9
Optimizing the spatial immune landscape of CD103+CD8+ tissue-resident memory T cells in non-small cell lung cancer by neoadjuvant chemotherapy	9
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers	9
Glioblastoma, from disease understanding towards optimal cell-based in vitro models	9
Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity	9
Annotation and functional characterization of long noncoding RNAs deregulated in pancreatic adenocarcinoma	9
FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination	9
Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis	9
Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1	9
Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer	9
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2	8
Lactate score classification of hepatocellular carcinoma helps identify patients with tumors that respond to immune checkpoint blockade therapy	8
Survivin degradation by bergenin overcomes pemetrexed resistance	8
VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma	8
Involvement of ACACA (acetyl-CoA carboxylase α) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts	8
Retraction Note: Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2	8
The ceramide synthase (CERS/LASS) family: Functions involved in cancer progression	8
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer	8
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma	8
Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia	8
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer	8
Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway	8
RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin	8
LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder	8
Comprehensive multiomics analysis of the signatures of gastric mucosal bacteria and plasma metabolites across different stomach microhabitats in the development of gastric cancer	8
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells	8
USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination	8
Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer	8
Integrating bulk and single-cell transcriptomics to elucidate the role and potential mechanisms of autophagy in aging tissue	8
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy	7
High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer	7
SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma	7
NK cells as powerful therapeutic tool in cancer immunotherapy	7
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis	7
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma	7
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing	7
Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study	7
Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization	7
Long non‐coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p	7
TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies	7
Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation	7
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia	7
Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression	7
Identification of a novel gene signature related to prognosis and metastasis in gastric cancer	6
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation	6
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis	6
Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study	6
Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling	6
TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8+ T cells in hepatocellular carcinoma	6
Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression	6
CEP55 3’-UTR promotes epithelial–mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p	6
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer	6
RETRACTED ARTICLE: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma	6
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration	6
A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma	6
Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects	6
A comprehensive review of SHP2 and its role in cancer	6
Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma	6
Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK	6
Spheroid-induced heterogeneity and plasticity of uveal melanoma cells	5
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment	5
Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin	5
RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST	5
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling	5
HPV16 E6/E7-mediated regulation of PiwiL1 expression induces tumorigenesis in cervical cancer cells	5
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine	5
How VEGF-A and its splice variants affect breast cancer development – clinical implications	5
Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis	5
Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer	5
Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein	5
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells	5
Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion	5
Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner	5

Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation	5
Retraction Note to: Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis	5
Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma	5
Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity	5
TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway	5
Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway	5
Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cells	5
Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi’s sarcoma-associated herpes virus	5
Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis	5
Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function	5
The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options	5
Retraction Note: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer	5
Publisher Correction to: RETRACTED ARTICLE: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN	5
PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA2	5
ADAR1 enhances tumor proliferation and radioresistance in non-small cell lung cancer by interacting with Rad18	5
Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution	5
Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report	4
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism	4
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models	4
TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner	4
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening	4
STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma	4
Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer	4
Identifying the effectiveness of 3D culture systems to recapitulate breast tumor tissue in situ	4
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer	4
Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics	4
Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma	4
Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer	4
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer	4
Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux	4
Cancer‐associated fibroblasts secrete hypoxia‐induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway	4
Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1	4
Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down	4
SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans	4
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer	4
Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity	4
ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity	4
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features	4
Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma	4
Altered iron metabolism as a target for ferroptosis induction in head and neck cancer	4
Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?	4
Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer	3
DNA hypomethylation patterns and their impact on the tumor microenvironment in colorectal cancer	3
TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer	3
DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis	3
Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance	3
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits	3
USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma	3
BCAT1 contributes to the development of TKI-resistant CML	3
Correction to: 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment	3
Targeting tumor associated macrophages (TAMs) reprograms tumor immune microenvironment to promote solid tumor immunotherapy	3
Senolytics: charting a new course or enhancing existing anti-tumor therapies?	3
Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers	3
Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer	3
IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling	3
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration	3
OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data	3
Retraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma	3
The survival prediction analysis and preliminary study of the biological function of YEATS2 in hepatocellular carcinoma	3
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications	3
YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma	3
Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer	3
3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment	3
A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells	3
Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination	3
Research advances in the molecular classification of gastric cancer	3
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models	3
Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress	3
Kavain ablates the radio-resistance of IDH-wildtype glioblastoma by targeting LITAF/NF-κB pathway	3
Roles of NRF2 in DNA damage repair	3
Non-canonical function of PHGDH promotes HCC metastasis by interacting with METTL3	3
Toxicity profiles of immunochemotherapy for gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis	3
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment	3
The emerging role of CARM1 in cancer	3
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis	3
TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradation	3
Correction to: EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma	3
Tertiary lymphoid structures and their therapeutic implications in cancer	3
Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection	3
RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis	3